Skip to content

Industrial Pharmacist

  • Home
  • Blog
  • Forums
  • Courses
  • Calculation
  • About Us
  • Privacy Policy
  • ANDA
  • ADL
  • FRD
  • QbD
  • QA
  • QC
  • RA
  • FDA
  • VS
  • SCM
  • Q&A
  • Dissolution
  • Data Integrity
  • Validation
  • Manufacturing
  • Packaging
  • Microbiology
Industrial Pharmacist
  • Optimizing Surfactant Selection in Dissolution Studies
    Dissolution

    Optimizing Surfactant Selection in Dissolution Studies

    Byipharmacist November 14, 2025November 14, 2025

    Surfactants play a key role in improving solubility and maintaining sink conditions, but using too much can artificially speed up drug release. If you get similar dissolution results across different concentrations, it’s best to go with the lowest level that is still physiologically relevant. Reproducibility matters – choose a concentration that gives consistent results across…

    Read More Optimizing Surfactant Selection in Dissolution StudiesContinue

  • Frequently Asked Questions About the Apex (Peak) Vessel
    Dissolution | Uncategorized

    Frequently Asked Questions About the Apex (Peak) Vessel

    Byipharmacist November 14, 2025

    One of the areas of the most focus in the dissolution world right now is the Apex vessel, which was formerly called the Peak vessel. With all of this new attention, I thought it would be good to answer some of the most common customers I get from scientists about this unique vessel. When should…

    Read More Frequently Asked Questions About the Apex (Peak) VesselContinue

  • Strategic Use of FOI-Based Biopharmaceutical Reviews in Generic Drug Development
    ANDA

    Strategic Use of FOI-Based Biopharmaceutical Reviews in Generic Drug Development

    Byipharmacist October 2, 2025October 2, 2025

    In the development of generic pharmaceutical products, aligning formulation design and regulatory strategy with prior approved data significantly improves the chances of first-time-right submissions. One highly effective method to gain such insight is through the use of biopharmaceutical review documents obtained via FOI requests. These documents, available publicly through regulatory agencies such as the USFDA…

    Read More Strategic Use of FOI-Based Biopharmaceutical Reviews in Generic Drug DevelopmentContinue

  • Affinity Chromatography: A Powerful Tool for Biomolecule Separation
    Analytical Development

    Affinity Chromatography: A Powerful Tool for Biomolecule Separation

    Byipharmacist October 2, 2025October 2, 2025

    Affinity Chromatography is one of the most powerful and precise techniques for the analysis and separation of biomolecules such as proteins, enzymes, and antibodies. Due to its high specificity and ability to isolate specific compounds from complex mixtures, it is highly popular in pharmaceutical industries, biotechnology, and biological research. Principle of Affinity Chromatography In this…

    Read More Affinity Chromatography: A Powerful Tool for Biomolecule SeparationContinue

  • Why Do We Incubate BET Reaction Tubes at 37°C for 60 Minutes?
    Sterilization

    Why Do We Incubate BET Reaction Tubes at 37°C for 60 Minutes?

    Byipharmacist August 16, 2025

    In the Bacterial Endotoxins Test (BET), incubating reaction tubes at 37°C ± 1 for exactly 60 ± 2 minutes is a key step. But why such specific conditions? Let’s dive in. 1. Optimal Enzyme Activity The heart of BET lies in the Limulus Amebocyte Lysate (LAL) reagent, sourced from horseshoe crab blood. This enzyme reacts…

    Read More Why Do We Incubate BET Reaction Tubes at 37°C for 60 Minutes?Continue

  • How to Finalize Tablet Weight?
    Tablet

    How to Finalize Tablet Weight?

    Byipharmacist August 16, 2025

    In pharmaceutical formulation development, finalizing the tablet weight is not a routine or arbitrary decision. It is a strategic choice that can significantly impact bioequivalence outcomes, patient compliance, manufacturing efficiency, and regulatory acceptance. This decision is influenced by multiple factors. Here’s how development teams typically approach it: Innovator (RLD) Tablet Weight as a Benchmark The…

    Read More How to Finalize Tablet Weight?Continue

  • Ideal Granule Size Distribution Based on Tablet Weight
    Manufacturing

    Ideal Granule Size Distribution Based on Tablet Weight

    Byipharmacist August 16, 2025August 16, 2025

    In pharmaceutical tablet manufacturing granule size plays a critical role in ensuring smooth processing, uniformity, flowability, and compressibility. The optimal granule size depends on multiple factors, including the tablet weight, dosage form type, API properties, and manufacturing method. While there is no strict one-size-fits-all rule, certain guidelines are generally followed based on tablet weight ranges….

    Read More Ideal Granule Size Distribution Based on Tablet WeightContinue

  • Types of Chromatography Columns
    Analytical Development

    Types of Chromatography Columns

    Byipharmacist August 16, 2025August 16, 2025

    Chromatography columns are crucial components in separation techniques, and they vary based on the type of chromatography used. Below are the main types of chromatography columns: Liquid Chromatography (LC) Columns Used in HPLC (High-Performance Liquid Chromatography) and UHPLC (Ultra-High-Performance Liquid Chromatography). Common types include: Gas Chromatography (GC) Columns Supercritical Fluid Chromatography (SFC) Columns Chiral Columns…

    Read More Types of Chromatography ColumnsContinue

Page navigation

1 2 3 … 43 Next PageNext

Popular Articles

  • Difference Between ISO Standards and EU GMP Annex 1

    Difference Between ISO Standards and EU GMP Annex 1

  • Titration in Pharmaceutical Industry

    Titration in Pharmaceutical Industry

  • Calculation of Peak Purity in HPLC

    Calculation of Peak Purity in HPLC

  • Analytical Method Validation | Avoiding Common Pitfalls in CTD Submissions

    Analytical Method Validation | Avoiding Common Pitfalls in CTD Submissions

  • Ensuring Compliance with 21 CFR Part 11 in Pharmaceutical Industry

    Ensuring Compliance with 21 CFR Part 11 in Pharmaceutical Industry

  • Audits in the Pharmaceutical Industry | Internal vs External

    Audits in the Pharmaceutical Industry | Internal vs External

  • USFDA Complaint Laboratory KPIs Measurements

    USFDA Complaint Laboratory KPIs Measurements

  • Difference Between Generic ANDA and 505(b)(2) Submissions

    Difference Between Generic ANDA and 505(b)(2) Submissions

  • Difference Between Disinfection and Sterilization

    Difference Between Disinfection and Sterilization

  • Key Elements of an Analytical Worksheet

    Key Elements of an Analytical Worksheet

  • Interview Questions and Answers on GMP

    Interview Questions and Answers on GMP

  • Quality by Design (QbD) and Design Space in Pharmaceutical Development

    Quality by Design (QbD) and Design Space in Pharmaceutical Development

  • CPP and CQA in Different Stages of Drug Product Manufacturing

    CPP and CQA in Different Stages of Drug Product Manufacturing

  • FDA Recall Classification System

    FDA Recall Classification System

  • Analytical Test Method Validation and Verification

    Analytical Test Method Validation and Verification

  • GLP vs GMP vs GCP | Similarities and Differences

    GLP vs GMP vs GCP | Similarities and Differences

  • Pharmaceutical Validation Interview Questions and Answers

    Pharmaceutical Validation Interview Questions and Answers

  • Difference Between Purity and Potency

    Difference Between Purity and Potency

  • Difference Between RLD and RS

    Difference Between RLD and RS

  • USFDA Databases

    USFDA Databases

© 2025 Industrial Pharmacist

  • Privacy Policy
  • DMCA
  • Contact Us
Industrial Pharmacist
Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}
  • Home
  • Blog
  • Forums
  • Courses
  • Calculation
  • About Us
  • Privacy Policy